Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Aug 6, 2020; 8(15): 3218-3229
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3218
Table 3 The effect of thalidomide treatment on refractory gastrointestinal bleeding due to vascular malformation
PatientDuration of treatment (mo)Recurrence of bleeding after 6 moNumber of hospitalizations due to GIB
Units RBC transfused
Number of endoscopic treatments (APC)
Comments
1 yr before thalidomideAfter starting thalidomide1 yr before thalidomideAfter starting thalidomide1 yr before thalidomideAfter starting thalidomide
16No2021020
219Yes4181231Side effect of fatigue and dizziness
345No2020010Side effect of neuropathy
414No10Weekly transfusion060Side effect of fatigue and constipation. Death
544Yes5114441Side effect of neuropathy. Death, Sepsis
617Yes65Biweekly transfusion432Stopped due to cost. Death
724Yes93339410Death
830Yes122821Side effect of fatigue
928Yes1784832121Death
103NA103010Stopped due to drug interaction
1125No201653121Death, Sepsis
126No2099094Side effect of neutropenia
133NA11121611